Apligraf
Ended Awarded
- Contract number
- SPE2D625F7F8A
- Awardee
-
Organogenesis Inc. UEI VKK3WXM4RCZ7
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,240
Award facts
- Contract value 100% obligated
- $1,239.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 65 offers Multiple Award, Fair Opportunity
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Canton, MA 02021, USA
Award details come from SAM.gov/FPDS.
About this award
On May 12, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,239.95 to Organogenesis Inc. for APLIGRAF, an advanced regenerative medicine product used in wound care and tissue regeneration. The contract is classified as fixed price with economic price adjustment and carries an ultimate completion date of May 15, 2025. This delivery order was issued without set-aside designation, reflecting Organogenesis's status as a standard commercial vendor competing in the open market. The place of performance is the contractor's headquarters in Canton, Massachusetts.
This delivery order is likely executed under one of Organogenesis's larger indefinite delivery vehicles with the Defense Logistics Agency or Department of Veterans Affairs, both of which have historically served as primary customers for the company's regenerative medicine solutions. Organogenesis maintains a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical (running through June 2026) and a $25 million single-award Indefinite Delivery Contract with the VA Headquarters for Surgical Implant Next Generation products (through September 2026). APLIGRAF, a specialized skin substitute product, supports critical wound treatment and surgical applications for military personnel and veterans across government healthcare systems.
Quick answers
Who was awarded contract SPE2D625F7F8A?
SPE2D625F7F8A was awarded to Organogenesis Inc. by Medical Supply Chain (Troop Support) on May 12, 2025.
How much is contract SPE2D625F7F8A worth?
The government has obligated $1,240 on SPE2D625F7F8A.
Is contract SPE2D625F7F8A an order under another contract?
Yes. SPE2D625F7F8A is a delivery order under SPE2DE21D0005, an indefinite delivery contract.
Was contract SPE2D625F7F8A competed?
The extent of competition for SPE2D625F7F8A was full and open competition after exclusion of sources. The government received 65 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award